HNGE Quote, Financials, Valuation and Earnings

GoodRx Holdings, Inc. has a net margin of -1.2% compared to Hinge Health, Inc.'s net margin of 0.57%. Hinge Health, Inc.'s return on equity of -104.84% beat GoodRx Holdings, Inc.'s return on equity of 4.78%.

Hinge Health, Inc. has a consensus price target of $64.29, signalling upside risk potential of 31.84%. On the other hand GoodRx Holdings, Inc. has an analysts' consensus of $4.88 which suggests that it could grow by 77.58%. Given that GoodRx Holdings, Inc. has higher upside potential than Hinge Health, Inc., analysts believe GoodRx Holdings, Inc. is more attractive than Hinge Health, Inc..

Hinge Health, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison GoodRx Holdings, Inc. has a beta of 1.470, suggesting its more volatile than the S&P 500 by 47.004%.

Hinge Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. GoodRx Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Hinge Health, Inc. pays -- of its earnings as a dividend. GoodRx Holdings, Inc. pays out -- of its earnings as a dividend.

Hinge Health, Inc. quarterly revenues are $154.2M, which are smaller than GoodRx Holdings, Inc. quarterly revenues of $196M. Hinge Health, Inc.'s net income of -$1.8M is lower than GoodRx Holdings, Inc.'s net income of $1.1M. Notably, Hinge Health, Inc.'s price-to-earnings ratio is -- while GoodRx Holdings, Inc.'s PE ratio is 32.01x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Hinge Health, Inc. is 7.47x versus 1.26x for GoodRx Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

GE Healthcare Technologies, Inc. has a net margin of -1.2% compared to Hinge Health, Inc.'s net margin of 9.02%. Hinge Health, Inc.'s return on equity of -104.84% beat GE Healthcare Technologies, Inc.'s return on equity of 24.49%.

Hinge Health, Inc. has a consensus price target of $64.29, signalling upside risk potential of 31.84%. On the other hand GE Healthcare Technologies, Inc. has an analysts' consensus of $89.22 which suggests that it could grow by 7.09%. Given that Hinge Health, Inc. has higher upside potential than GE Healthcare Technologies, Inc., analysts believe Hinge Health, Inc. is more attractive than GE Healthcare Technologies, Inc..

Hinge Health, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison GE Healthcare Technologies, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Hinge Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. GE Healthcare Technologies, Inc. offers a yield of 0.17% to investors and pays a quarterly dividend of $0.04 per share. Hinge Health, Inc. pays -- of its earnings as a dividend. GE Healthcare Technologies, Inc. pays out 2.88% of its earnings as a dividend. GE Healthcare Technologies, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Hinge Health, Inc. quarterly revenues are $154.2M, which are smaller than GE Healthcare Technologies, Inc. quarterly revenues of $5.1B. Hinge Health, Inc.'s net income of -$1.8M is lower than GE Healthcare Technologies, Inc.'s net income of $464M. Notably, Hinge Health, Inc.'s price-to-earnings ratio is -- while GE Healthcare Technologies, Inc.'s PE ratio is 17.23x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Hinge Health, Inc. is 7.47x versus 1.89x for GE Healthcare Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

National Research Corp. has a net margin of -1.2% compared to Hinge Health, Inc.'s net margin of 11.54%. Hinge Health, Inc.'s return on equity of -104.84% beat National Research Corp.'s return on equity of 61.55%.

Hinge Health, Inc. has a consensus price target of $64.29, signalling upside risk potential of 31.84%. On the other hand National Research Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Hinge Health, Inc. has higher upside potential than National Research Corp., analysts believe Hinge Health, Inc. is more attractive than National Research Corp..

Hinge Health, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison National Research Corp. has a beta of 0.447, suggesting its less volatile than the S&P 500 by 55.256%.

Hinge Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. National Research Corp. offers a yield of 2.53% to investors and pays a quarterly dividend of $0.12 per share. Hinge Health, Inc. pays -- of its earnings as a dividend. National Research Corp. pays out 45.99% of its earnings as a dividend. National Research Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Hinge Health, Inc. quarterly revenues are $154.2M, which are larger than National Research Corp. quarterly revenues of $34.6M. Hinge Health, Inc.'s net income of -$1.8M is lower than National Research Corp.'s net income of $4M. Notably, Hinge Health, Inc.'s price-to-earnings ratio is -- while National Research Corp.'s PE ratio is 26.97x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Hinge Health, Inc. is 7.47x versus 3.11x for National Research Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Spok Holdings, Inc. has a net margin of -1.2% compared to Hinge Health, Inc.'s net margin of 9.46%. Hinge Health, Inc.'s return on equity of -104.84% beat Spok Holdings, Inc.'s return on equity of 10.88%.

Hinge Health, Inc. has a consensus price target of $64.29, signalling upside risk potential of 31.84%. On the other hand Spok Holdings, Inc. has an analysts' consensus of $20.00 which suggests that it could grow by 62.04%. Given that Spok Holdings, Inc. has higher upside potential than Hinge Health, Inc., analysts believe Spok Holdings, Inc. is more attractive than Hinge Health, Inc..

Hinge Health, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Spok Holdings, Inc. has a beta of 0.438, suggesting its less volatile than the S&P 500 by 56.19%.

Hinge Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spok Holdings, Inc. offers a yield of 9.65% to investors and pays a quarterly dividend of $0.31 per share. Hinge Health, Inc. pays -- of its earnings as a dividend. Spok Holdings, Inc. pays out 171.77% of its earnings as a dividend.

Hinge Health, Inc. quarterly revenues are $154.2M, which are larger than Spok Holdings, Inc. quarterly revenues of $33.9M. Hinge Health, Inc.'s net income of -$1.8M is lower than Spok Holdings, Inc.'s net income of $3.2M. Notably, Hinge Health, Inc.'s price-to-earnings ratio is -- while Spok Holdings, Inc.'s PE ratio is 16.19x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Hinge Health, Inc. is 7.47x versus 1.92x for Spok Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.